Back to search

United Kingdom· GB-APID-16180611000001103

Flixotide 2mg/2ml Nebules

A fluticasone product containing fluticasone, registered in United Kingdom by Lexon (UK) Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC R03BA05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedFlixotide 2mg/2ml NebulesATCR03BA05REGISTER NO.GB-APID-1618061100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Fluticasone is registered in 16 of 19 countries.

Countries holding a registration under ATC R03BA05 (fluticasone), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose

Fluticasone · ATC R03BA05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Fluticasone
Manufacturer
Lexon (UK) Ltd
Country
United Kingdom (GB)
ATC code
R03BA05
ATC class
Fluticasone
Defined daily dose
0.6 mg, Inhal
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

576 interactions on record for fluticasone.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fluticasone · interactions on record

576 records

  • 35 severe
  • 44 moderate
  • 20 minor
  • 475 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • MifepristoneG03XB01severe
  • DesmopressinH01BA02severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Flixonase Aquosum, Flixotide Diskus Forte
  • Belgium · Flixonase Aqua, Flixotide
  • Bulgaria · Аркуист, Фликсоназе
  • Cyprus · Cutivate, Flixonase Aqueous
  • Czechia · Flixotide Diskus, Flixotide Inhaler N
  • Germany · Flutica, Fluticason Cipla
  • Denmark · Flixotide, Flurhin
  • Estonia · Cutivate Cream, Flixonase
  • Spain · Avancort, Flixonase
  • Finland · Flixonase, Flixotide Diskus
  • France · Fixorinox, Flixonase
  • Greece · Alerxem, Bocacort-S
  • Croatia · Flixonase, Flixotide Inhaler
  • Hungary · Cutivate, Flixonase
  • Ireland · Arquist, Flixonase Allergy Relief
  • Iceland · Avamys, Flixotide
  • Italy · Aktanos, Deflut
  • Liechtenstein · Avamys
  • Lithuania · Cutivate, Flixotide
  • Luxembourg · Flixonase Aqua, Flixotide
  • Latvia · Flixonase, Flixotide
  • Malta · Cutivate, Flihaler
  • Netherlands · Cortifil, Cutivate
  • Norway · Avamys, Flurhin
  • Poland · Cutivate, Fanipos
  • Portugal · Brisovent Diskus, Brisovent Inalador
  • Romania · Arquist, Cutivate
  • Sweden · Arquist, Fluticasone Cipla
  • Slovenia · Flixonase, Flixotide
  • Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cfc28faf-bfa6-49bd-af64-7720cdfde51d
GET /v1/drugs/cfc28faf-bfa6-49bd-af64-7720cdfde51d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "16180611000001103",
  "desc": "Flixotide 2mg/2ml Nebules (Lexon (UK) Ltd)",
  "form": "Nebuliser liquid",
  "vpid": "39712511000001104",
  "source": "dmd",
  "vtm_id": "776016008",
  "strength": "1 mg",
  "substance": "Fluticasone",
  "ingredient": "Fluticasone propionate",
  "supplier_code": "3415501000001104"
}

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.